NCT05751408 Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
| NCT ID | NCT05751408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roessingh Research and Development |
| Condition | Gait Analysis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-01-25 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-01-25 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A standard clinical gait analysis consists of observing walking with video (2D) or advanced equipment (VICON 3D). This 3D method provides detailed information about the gait pattern, but is time-consuming in implementation and data analysis. There are commercial 3D systems on the market that are used in healthy individuals and in sports. These so-called Inertial Measurement Units (IMUs) may also be suitable for use in the clinic. In this research protocol, the aim is to test the usability of commercial sensors and technically compare them with standard clinical 3D gait analysis in adult patients with a neurological disorder.
Eligibility Criteria
Subjects referred for clinical gait analysis at Roessingh Centre for Rehabilition in Enschede, the Netherlands: Inclusion Criteria: * Disorders affecting walking, including amongst others stroke, traumatic brain injury, MS, incomplete spinal cord injury, CP, Spina Bifida, neuromuscular diseases * age minimum 18 years * Viosca score minimum 2; meaning minimal independent walking ability indoors * increased fall risk or increased effort of walking because of: 1) decreased stability during stance; and/or 2) decreased foot clearance during swing; and/or 3) not able to walk on bare feet because of equinovarus; and/or 4) fatigue during walking because of compansatory strategies. Exclusion Criteria: * subjects referred for clinical gait analysis because of problems other than stiff knee gait or foot surgery * severe deficits in communication, memory and understanding at such a level that it would affect instructions during the measurements
Contact & Investigator
C Nikamp, PhD
PRINCIPAL INVESTIGATOR
Roessingh Research and Development
Frequently Asked Questions
Who can join the NCT05751408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gait Analysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05751408 currently recruiting?
Yes, NCT05751408 is actively recruiting participants. Contact the research team at c.nikamp@rrd.nl for enrollment information.
Where is the NCT05751408 trial being conducted?
This trial is being conducted at Enschede, Netherlands.
Who is sponsoring the NCT05751408 clinical trial?
NCT05751408 is sponsored by Roessingh Research and Development. The principal investigator is C Nikamp, PhD at Roessingh Research and Development. The trial plans to enroll 40 participants.